IJCOPE Journal

UGC Logo DOI / ISO Logo

International Journal of Creative and Open Research in Engineering and Management

A Peer-Reviewed, Open-Access International Journal Supporting Multidisciplinary Research, Digital Publishing Standards, DOI Registration, and Academic Indexing.
Journal Information
ISSN: 3108-1754 (Online)
Crossref DOI: Available
ISO Certification: 9001:2015
Publication Fee: 599/- INR
Compliance: UGC Journal Norms
License: CC BY 4.0
Peer Review: Double Blind
Volume 02, Issue 6

Published on: June 2026

A THERAGNOSTIC APPROACH TO BLOCK THE PATHOGENICITY OF CORONAVIRUS DURING CRISES OF’ ANTIMICROBIAL RESISTANCE

Zeba Khalid

Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202002 India.
DOI:https://doi.org/10.55041/ijcope.v2i6.316

Article Status

Plagiarism Passed Peer Reviewed Open Access

Available Documents

Download PDF Review Report

Abstract

The COVID-19 pandemic has emphasized the need for advanced therapeutics that are rapid, sensitive, and multiplexed to treat the virus and its variants. One promising technique that has emerged for combating viruses is CRISPR, a genome editing tool that can enable precise and rapid theragnostic with just the knowledge of a microbe’s genome sequence. In this overview, we discuss the different types of CRISPR tools, their mechanisms, and their applicability in detecting viral variants. However, the practical applications of CRISPR/Cas systems are currently limited by the lack of efficient delivery equipment. Although adeno-associated viruses (AAV) and nanoparticles are potential delivery systems, they require extensive optimization for in vivo gene editing. Despite the challenges and limitations, the use of CRISPR as a theragnostic tool shows promise for blocking the pathogenicity of coronaviruses.

Key words: CoV – CRISPR/Cas - Theragnostic – Nanoparticles

How to Cite this Paper

Khalid, Z. (2026). A theragnostic approach to block the pathogenicity of coronavirus during crises of’ antimicrobial resistance. International Journal of Creative and Open Research in Engineering and Management, <i>02</i>(6). https://doi.org/10.55041/ijcope.v2i6.316

Khalid, Zeba. "A theragnostic approach to block the pathogenicity of coronavirus during crises of’ antimicrobial resistance." International Journal of Creative and Open Research in Engineering and Management, vol. 02, no. 6, 2026, pp. . doi:https://doi.org/10.55041/ijcope.v2i6.316.

Khalid, Zeba. "A theragnostic approach to block the pathogenicity of coronavirus during crises of’ antimicrobial resistance." International Journal of Creative and Open Research in Engineering and Management 02, no. 6 (2026). https://doi.org/https://doi.org/10.55041/ijcope.v2i6.316.

Search & Index

Google Scholar Crossref DOI ResearchGate

References


  1. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens. 2020 Mar 20;9(3):231.

  2. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Advances in virus research. 2011 Jan 1;81:85-164.

  3. Nguyen TM, Zhang Y, Pandolfi PP. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. Cell Research. 2020 Mar;30(3):189-90. W.T. Harvey, A.M. Carabelli, B. Jackson,

  4. Tiwari R, Dhama K, Sharun K, Iqbal Yatoo M, Malik YS, Singh R, Michalak I, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ. COVID-19: animals, veterinary and zoonotic links. Veterinary Quarterly. 2020 Jan 1;40(1):169-82.

  5. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature microbiology. 2020 Apr 1;5(4):536-44.

  6. Yadav PD, Potdar VA, Choudhary ML, Nyayanit DA, Agrawal M, Jadhav SM, Majumdar TD, Shete-Aich A, Basu A, Abraham P, Cherian SS. Full-genome sequences of the first two SARS-CoV-2 viruses from India. The Indian journal of medical research. 2020 Feb;151(2-3):200.

  7. Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, Dhama K, Yatoo MI, Bonilla-Aldana DK, Rodriguez-Morales AJ. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020 Jun 1;28(2):174-84.

  8. Rambaut A, Lipkin W, Holmes E, Kristian G. The proximal origin of SARS-CoV-2. Nature. 2020;26:450-2.

  9. Coutard B, Valle C, De Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral research. 2020 Apr 1;176:104742.

  10. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020 Mar 27;12(4):372.

Ethical Compliance & Review Process

  • •All submissions are screened under plagiarism detection.
  • •Review follows editorial policy.
  • •Authors retain copyright.
  • •Peer Review Type: Double-Blind Peer Review
  • •Published on: Jun 25 2026
CCBYNC

This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share and adapt this work for non-commercial purposes with proper attribution.

View License
Back to Volume 02, Issue 6View All Issues Next Article

← Previous Article

A Survey on Sports Club Management System: Features, Challenges and Functionality

Next Article →

Adaptive Converter Control for Enhancing Grid Stability in Renewable Energy Networks
Scroll to Top